There are many divergent views regarding value at this time. Dilution is significant and ongoing.
I recommend not believing the news releases until the company proves the forward looking statements within them.
I gathered what I could across the past two weeks and added it to the bottom half of the iBox (section with white background). I will continue to update this information.
At this time, they operate under a non-exclusive license to manufacture and distribute an antibiotic known as Viabecline--a Phillips company product aka Diabecline. Seems Dr. Otiko added two ingredients and now calls it his own.
I found its market value is 8mil as well from Internet, but how do you (Whatarush12) know it is significantly undervalued?
Besides, I sent the company a message as well, but no reply. Could somebody from the company clarify the situation for us in public?